1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. MERUS N.V
Merus N.V XNAS: MRUS

Merus N.V Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment compr...

Read More
54.50 -0.61 (-1.11%)
64.21% Gain from 52W Low
315.8K
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
5.7 / 100
Momentum Score
Technically Neutral
59.1 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
90
1Yr Price target upside is 66%
15 analysts

11

S

8

W

1

O

2

T

SWOT Analysis

Merus N.V Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..